Arthrex ACP® Double-Syringe System

100% Autologous Fluid PRF With 2-3× Platelet Concentration

What Is the Arthrex
ACP Double-Syringe System?

 

The Arthrex ACP double-syringe system delivers 100% autologous fluid PRF (platelet-rich fibrin) with 2-3×platelet concentration—processed in a closed, sterile system without synthetic separation materials.

Clinically proven to work for skin rejuvenation, hair restoration, scar reduction, and other regenerative treatments, it ensures purity, reproducibility, and clinical confidence.

How It Works

1. Blood Collection

A small amount of the patient’s blood is drawn directly into the Arthrex ACP double syringe.

2. Centrifugation

The syringe is placed in a precision-engineered centrifuge to separate the plasma from other blood components.

3. Application

The resulting autologous conditioned plasma (ACP), a fluid PRF rich in growth factors and fibrin, is ready for immediate use in treatments such as skin rejuvenation, scar reduction, and hair restoration.

 

Key Benefits

Explore how the Arthrex ACP double-syringe system can enhance your practice.

For Your Practice

  • Intuitive design minimizes training requirements and allows for efficient use.
  • Reliable and consistent results supported by scientific evidence.
  • Reduces the need for complex or synthetic materials in procedures.

For Your Patients

  • Completely natural treatments that use only the patient’s own biological substances
  • Negligible risk of allergic reactions or side effects since the treatment is 100% autologous
  • Minimal discomfort and no burning sensation during or after procedures because no anticoagulant is used

Ready to integrate the Arthrex ACP double-syringe system into your practice?

CONTACT US NOW

SAFETY AND EFFECTIVNESS

Scientific Validation and Clinical Evidence

The Arthrex ACP double-syringe system is rooted in decades of research and clinical application. These systems are designed to meet the highest safety standards, making them valuable tools for aesthetic professionals seeking minimally invasive, evidence-based treatments.

Arthrex ACP Safe for Surgical Scar Treatment

Reference: Platelet-rich plasma in the treatment of subcutaneous venous access device scars: a head-to-head patient survey. BIomed Res Int. 2015;2015:630601. -Eichler C, Najapour M, Sauerwald A, Puppe J, Warm M. – Source: doi:10.1155/2015/630601

PRP for Deep Perianal Burn using PRP: A Case Report

Reference: A novel approach to non-surgical management of deep second-degree perianal burn in an immobile patient using platelet-rich plasma: A case report Hannover Medical School (MHH) – Tamulevicius M, Vogt PM, Maerz V – Source: 10.1016/j.burnso.2025.100395

Leukocyte-Reduced PRP Boosts Stem Cell Growth

Reference: The effect of leukocyte-reduced platelet-rich plasma on the proliferation of autologous adipose-tissue derived mesenchymal stem cells. Clin Hemorheol Microcirc. 2016;61(4):599-614. – Loibl M, Lang S, Brockhoff G, et al. – Source: doi:10.3233/CH-141920

Optimal Cell Growth Shown at 2.5x PRP Concentration

Reference: The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts Clin Oral Implants Res. – Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M – Source: 17(2):212–219

High Patient Satisfaction With PRP for Pattern Hair Loss

Reference: Patient satisfaction and clinical effects of platelet-rich plasma on pattern hair loss in male and female patients Concept Medical – Hetz SP, Martin J, Pototschnig H – Source: 10.7759/cureus.28801

PRP Quality Depends on System and Preparation Method

Reference: Platelet-rich plasma differs according to preparation method and human variability *J Bone Joint Surg Am* – Mazzocca AD, McCarthy MB, Chowaniec DM, et al. – Source: 94(4):308-316
&nbsp

PRP Safe for Use After Sentinel Lymph Node Biopsies

Reference: Platelet-rich plasma (PRP) in breast cancer patients: An application analysis of 163 sentinel lymph node biopsies Biomed Res Int – Eichler C, Baucks C, Uner J, et al – Source: 2020:3432987

PRP Proven Effective for Aesthetic Treatments

Reference: Illustrated Guide to Collagen Induction with Platelet-Rich Plasma (PRP): Rejuvenation Face, Neck, Décolleté, Hands. KVM – Der Medizinverlag – Kolster B, Paasch U. Quintessence Publishing; – Source: 2019.

ACP Produces Autologous Fluid PRF Without Anticoangulants

Reference: Platelet-rich plasma for skin rejuvenation and treatment of actinic elastosis in the lower eyelid area. Cureus. 2018;10(7):e2999. -Aust M, Pototschnig H, Jamachi S, Busch KH. – Source: doi10.7759/cureus.2999

Why Choose Arthrex Aesthetics?

We invite you to learn more about Arthrex and the positive contributions we are making to medicine and
the communities we serve.

 

INNOVATIVE


Cutting-edge regenerative technology, developed with precision.

 

EFFICIENT

User-friendly system with minimal processing time.

 

SAFE

Closed-loop automation ensures sterility and consistency.

 

SUPPORTIVE

Training, resources, and ongoing physician education.

FAQs

What can the Arthrex ACP double Syringe be used for?

The Arthrex ACP double syringe is used for the preparation of fluid PRF from the patient’s own blood. When injected into the treatment area, this fluid PRF stimulates the body’s own hyaluronic acid and collagen synthesis, cell proliferation, and regeneration. Studies show its clinical effectiveness for skin rejuvenation, wound treatment, scar reduction, hair restoration, and more.

What does ACP Stand For? And is there a difference between ACP and Fluid PRF

ACP stands for “autologous conditioned plasma” and can be classified as a fluid PRF (platelet-rich fibrin) system as it effectively concentrates the patient’s platelets in the plasma phase and does not involve the usage of any synthetic additives for anticoagulation or separation. It is 100% autologous and can be readily injected after preparation into the treatment area as it is still liquid after the centrifugation step.

What are the benefits of the Arthrex ACP System compared to other treatment systems?

The Arthrex ACP system is a natural treatment that leverages the body’s own regeneration processes, with over 200 clinical studies supporting its effectiveness. It features an optimized composition rich in fibrinogen, minimal pain during injection due to the absence of anticoagulants, and a fast, safe, and user-friendly production system using a double syringe.

What are the potential side effects and risks of ACP treatment?

ACP uses autologous plasma derived from the patient’s own blood, which makes the likelihood of immune reactions negligible. There may be some temporary redness or mild swelling immediately following the procedure, which should subside quickly. As with any aesthetic procedure, treatment should be conducted by a trained health care professional following medical guidelines.

How is ACP different from other plasma treatments?

ACP is produced in a closed system without synthetic separating materials and does not require an anticoagulant, unlike some other plasma treatments. It uses physical separation by centrifugation and an innovative double-chamber syringe to ensure a higher concentration of platelets and reduced white blood cells and erythrocytes.